Press release
Otava Alzheimer’s Disease Targeted Libraries
Otava offers 29 Alzheimer’s disease Targeted Libraries designed with Ligand-based and Receptor-based approach. These libraries contain only drug-like compounds. All molecules have enhanced potential for CNS bioavailability. Filtering by polar surface area parameter (PSA) which discriminates CNS penetrating compounds, we selected only those compounds having increased blood-brain barrier (BBB) permeability.
In this collection of targeted libraries we included those activities which can be divided into two Alzheimer’s treatment categories: (i) disease-modifying treatments that target and reduce the secondary pathologies of the disease, leading to the cessation or the reversal of disease progression; and (ii) symptomatic treatments that treat cognitive symptoms of the disease and protect from further cognitive decline.
We hope that Otava Targeted Libraries can help scientists and pharmaceutical companies racing to develop treatments that address the underlying Alzheimer’s disease processes.
OTAVA Ltd. is an international science-based chemical company founded in 1997 with production laboratories and offices in Europe (Kiev, Ukraine) and North America (Toronto, Canada).
Our company carries a diverse set of products and services for pharmaceutical companies, universities, research institutes and government agencies. We specialize in the development and production of featured chemicals, bio-chemicals and bioanalytical reagents.
Our newly created well-equipped kilo-lab provides multi-kilo scale-up preparation service for the clients.
Our facilities and highly-experienced personnel make possible a variety of contract research projects and custom syntheses of complex biologically active substances. Our Molecular Modelling Department provides the full range of advanced computational services.
OTAVA Ltd.
150 Zabolotnogo St.
Kyiv 143, 03143
Ukraine
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Otava Alzheimer’s Disease Targeted Libraries here
News-ID: 188665 • Views: …
More Releases from Otava Ltd.
Search Otava Chemical Collections On-Line
In recent years, remarkable progress has been made and miraculous results produced in the field of synthetic chemistry. However, searching for desired chemical compounds among variety of chemical databases becomes more and more complex.
Otava Ltd., a leading provider of synthetic organic compounds for research and drug discovery, - offers a number of products including focused libraries, screening compounds libraries and chemical building blocks. Our combined databases comprise more…
More Releases for Alzheimer’s
Increasing Global Prevalence of Alzheimer’s and Improvising Regulatory Scenari …
Alzheimer’s disease is a neurodegenerative disorder that causes slow decline in abilities such as thinking, reasoning, and routine daily activities, alongside memory loss. This may lead to planning or solving problems, poor judgment, lack of social activities, and personality and mood changes, which are considered the most common symptoms of Alzheimer’s disease. Symptoms of Alzheimer’s disease generally begin to appear in patients in their mid-sixties. As per World Alzheimer’s report,…
Media Advisory: Alzheimer’s Disease Resource Center, Inc. Presents 10th Annual …
Who: Mary Ann Malack-Ragona, Executive Director/Chief Executive Officer, Alzheimer’s Disease Resource Center, Inc. (ADRC)
Participating Walk for Alzheimer’s teams and individuals
Mickey B, Radio Personality, WGBB Radio and Master of Ceremonies
Ronald McDonald
The Liberty Bells, USO troupe
What: Alzheimer’s Disease Resource Center, Inc. (ADRC) is presenting its 10th Annual Old Bethpage Walk for Alzheimer’s & Mexican Fiesta. There will be an opening ceremony with Mickey B, Radio Personality, WGBB Radio, as the Master of…
Home Care Assistance Partners with the Alzheimer’s Association to Promote Earl …
(Palo Alto, CA – November 29, 2011) Home Care Assistance, North America’s leading provider of in-home care for seniors, announced today that, along with companies including Genworth, Starbucks, Intel and Pfizer, they are now a Champion Partner of the Alzheimer’s Early Detection Alliance (AEDA). The AEDA is a program renowned for raising Alzheimer’s awareness and promoting early detection of the disease. As a member of this important alliance, Home…
Alzheimer’s Association Long Island Announces Release of Latest Report on Alzh …
Alzheimer’s Association Long Island announced the release of the most recent report about Alzheimer’s disease. “Alzheimer’s from the Frontlines: Challenges a National Alzheimer’s Plan Must Address” provides a look into the unrelenting challenges brought on by this disease by offering insights and perspectives from individuals across the country who participated in the Alzheimer’s Association’s public input process. The Association and over 70 of its chapters hosted 132 input sessions throughout…
Alzheimer’s Association Long Island Presents Public Input Session for National …
On August 24, Alzheimer’s Association Long Island will hold a public input session to solicit views, comments and perspectives from stakeholders in the Alzheimer’s community to assist in the development of a successful National Alzheimer’s Plan. The recommendations and comments expressed during these input sessions, taking place across the country in August, will be collected and shared this fall with officials from the U.S. Department of Health and Human Services,…
Alzheimer’s Association Long Island Releases “2011 Alzheimer’s Facts and F …
Ronkonkoma, NY — Alzheimer’s Association Long Island released its “2011 Alzheimer’s Disease Facts and Figures” report, which this year included a special section on early detection and diagnosis of Alzheimer’s.
According to the report, there are an estimated 14.9 million unpaid caregivers who are providing care to 5.4 million people with Alzheimer’s disease. In addition, Alzheimer’s disease costs the American healthcare system $183 billion annually.
“2011 Alzheimer’s Disease Facts and Figures” provides…
